- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AstraZeneca PLC BDR (A1ZN34)
Track today's live AstraZeneca BDR (A1ZN34) share price, performance and key data on this page with our current B3:A1ZN34 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the AstraZeneca BDR share price on the B3 exchange. Use the dropdown to switch exchange for the A1ZN34 share price, head to our technical summary section, which provides analysis on AstraZeneca BDR share price buy/sell indicators using real-time data (or discuss the AstraZeneca BDR (A1ZN34) stock price today with other investors in the AstraZeneca BDR BVMF share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BVMF:A1ZN34 share price (ISIN: BRA1ZNBDR003) to enhance your trading decisions with our free investment tools and resources.
What Is the AstraZeneca PLC BDR Share Price Today?
The AstraZeneca BDR share price today is 132.90.
What Is the Stock Symbol for AstraZeneca PLC BDR
The stock symbol (or 'ticker') for AstraZeneca PLC BDR is "A1ZN34."
What Stock Exchange Does AstraZeneca PLC BDR Trade On?
AstraZeneca PLC BDR is listed and trades on the B3 stock exchange.
Is AstraZeneca PLC BDR a Good Stock to Buy?
Determining whether AstraZeneca BDR (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current BVMF:A1ZN34 share price (ISIN: BRA1ZNBDR003) to enhance your trading decisions with our free investment tools and resources.
What Is the AstraZeneca PLC BDR Share Price Today?
The AstraZeneca BDR share price today is 132.90.
What Is the Stock Symbol for AstraZeneca PLC BDR
The stock symbol (or 'ticker') for AstraZeneca PLC BDR is "A1ZN34."
What Stock Exchange Does AstraZeneca PLC BDR Trade On?
AstraZeneca PLC BDR is listed and trades on the B3 stock exchange.
Is AstraZeneca PLC BDR a Good Stock to Buy?
Determining whether AstraZeneca BDR (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
132.90
-0.50(-0.37%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
131.77
133.40
52 wk Range
129.06
188.43
A1ZN34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
131.77133.40
52 wk Range
129.06188.43
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.03%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.03%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
A1ZN34 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Form 4 Quantumscape Corp For: 8 October- Investing.com
Form 4 ASTRAZENECA PLC For: 8 October- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Earnings
Latest Release
27/07/2026
EPS / Forecast
1.61 / --
Revenue / Forecast
15.38B / --
Compare A1ZN34 to Peers and Sector
Metrics to compare | A1ZN34 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipA1ZN34PeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.4x | 22.9x | −0.3x | |
PEG Ratio | 0.90 | 0.31 | 0.00 | |
Price/Book | 4.9x | 4.9x | 2.6x | |
Price / LTM Sales | 4.0x | 4.5x | 3.0x | |
Upside (Analyst Target) | - | 34.4% | 61.4% | |
Fair Value Upside | Unlock | 7.7% | 7.4% | Unlock |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the AstraZeneca BDR (B3: A1ZN34) Share Price Today?
The AstraZeneca BDR stock price today is 132.90 BRL.
What Stock Exchange Does AstraZeneca BDR (A1ZN34) Trade On?
AstraZeneca BDR is listed and trades on the B3 Stock Exchange.
What Is the Ticker (Stock Symbol) for AstraZeneca BDR?
The stock symbol (also called a 'ticker') for AstraZeneca BDR is "A1ZN34."
Does AstraZeneca BDR Pay Dividends? What’s The Current A1ZN34 Dividend Yield?
Yes, A1ZN34 Pays Dividends to its Shareholders. The current AstraZeneca BDR dividend yield is 2.03%.
What Is the Current AstraZeneca BDR Market Capitalisation?
As of today, AstraZeneca BDR (B3: A1ZN34) market cap is 1.23T BRL.
What Is AstraZeneca BDR's (A1ZN34) Earnings Per Share (TTM)?
The AstraZeneca BDR EPS is currently 6.68 (Trailing Twelve Months).
Is A1ZN34 a Buy or Sell From a Technical Analyst Perspective?
Based on today's AstraZeneca BDR moving averages and other technical indicators, the daily buy/sell signal for A1ZN34 stock is Strong Sell.
How Many Times Has AstraZeneca BDR Stock Split?
AstraZeneca BDR has split 1 times. (See the A1ZN34 stock split history page for full effective split date and price information.)
How Many Employees Does AstraZeneca BDR Have?
AstraZeneca BDR has 96100 employees, based on their latest Companies House report.
What is the current trading status of AstraZeneca BDR (B3: A1ZN34)?
As of 10/10/2026, AstraZeneca BDR (A1ZN34) is trading at a share price of 132.90 BRL, with a previous close of 132.90 BRL. The stock has fluctuated within a day range of 131.77 BRL to 133.40 BRL, while its 52-week range spans from 129.06 BRL to 188.43 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.